20 Years of Experience
Melanie is a reporter, commentator, and industry analyst within the biopharmaceutical and medtech industry. Melanie is a specialist within consulting across market access, pricing, outcomes-based care, precision medicine, digital health, AI, R&D strategies and consumer empowerment for a range of clients in biopharma and investment community. Her expertise is valued at Wharton Business School's Pharmaceutical Executive course training in the area of pricing and market access modules.
She is a speaker and presenter for corporate development and strategist teams and moderator at key industry events.
Melanie is a graduate of the University Of Cambridge with a Bachelor’s degree in Natural Science and has earned her Master degree from the University of Sheffield in International Health Technology Assessment, Pricing, and Reimbursement